55 related articles for article (PubMed ID: 38751976)
21. Association between trans fatty acids and COVID-19: A multivariate Mendelian randomization study.
Liu X; Du Z; Wang J; Wang Q; Zheng Y; Niu L; Hao C; Xue D; Zhang Y
J Med Virol; 2023 Feb; 95(2):e28455. PubMed ID: 36597904
[TBL] [Abstract][Full Text] [Related]
22. Decrease of cancer diagnosis during COVID-19 pandemic: a systematic review and meta-analysis.
Angelini M; Teglia F; Astolfi L; Casolari G; Boffetta P
Eur J Epidemiol; 2023 Jan; 38(1):31-38. PubMed ID: 36593334
[TBL] [Abstract][Full Text] [Related]
23. Infection with SARS-CoV-2 as a potential achalasia trigger.
Ruz Zafra P; García Sánchez CJ; Pérez Ramírez A; Guil Soto A; Leo Carnerero E
Rev Esp Enferm Dig; 2023 Apr; 115(4):203-204. PubMed ID: 36093995
[TBL] [Abstract][Full Text] [Related]
24. The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020.
Morgan E; Soerjomataram I; Rumgay H; Coleman HG; Thrift AP; Vignat J; Laversanne M; Ferlay J; Arnold M
Gastroenterology; 2022 Sep; 163(3):649-658.e2. PubMed ID: 35671803
[TBL] [Abstract][Full Text] [Related]
25. Lethality of Birth Defects in Live Born Infants Categorized by Gestational Age and Birth Weight.
Rittler M; Campaña H; Heisecke S; Ratowiecki J; Elias D; Gimenez L; Poletta FA; Gili J; Pawluk M; Santos MR; Uranga R; Cosentino V; Camelo JL
Am J Perinatol; 2023 Oct; 40(13):1406-1412. PubMed ID: 34634830
[TBL] [Abstract][Full Text] [Related]
26. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19.
Taquet M; Dercon Q; Luciano S; Geddes JR; Husain M; Harrison PJ
PLoS Med; 2021 Sep; 18(9):e1003773. PubMed ID: 34582441
[TBL] [Abstract][Full Text] [Related]
27. Th2/Th1 Cytokine Imbalance Is Associated With Higher COVID-19 Risk Mortality.
Pavel AB; Glickman JW; Michels JR; Kim-Schulze S; Miller RL; Guttman-Yassky E
Front Genet; 2021; 12():706902. PubMed ID: 34335703
[TBL] [Abstract][Full Text] [Related]
28. SARS-CoV-2 infection during pregnancy and risk of preeclampsia: a systematic review and meta-analysis.
Conde-Agudelo A; Romero R
Am J Obstet Gynecol; 2022 Jan; 226(1):68-89.e3. PubMed ID: 34302772
[TBL] [Abstract][Full Text] [Related]
29. Inflammation and tumor progression: signaling pathways and targeted intervention.
Zhao H; Wu L; Yan G; Chen Y; Zhou M; Wu Y; Li Y
Signal Transduct Target Ther; 2021 Jul; 6(1):263. PubMed ID: 34248142
[TBL] [Abstract][Full Text] [Related]
30. SARS-COV2 and eosinophilic esophagitis: a first case.
Mennini M; Rea F; Riccardi C; De Angelis P; Tambucci R
Eur J Gastroenterol Hepatol; 2021 Aug; 33(8):1131-1132. PubMed ID: 34213509
[No Abstract] [Full Text] [Related]
31. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records.
Taquet M; Geddes JR; Husain M; Luciano S; Harrison PJ
Lancet Psychiatry; 2021 May; 8(5):416-427. PubMed ID: 33836148
[TBL] [Abstract][Full Text] [Related]
32. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis.
Wei SQ; Bilodeau-Bertrand M; Liu S; Auger N
CMAJ; 2021 Apr; 193(16):E540-E548. PubMed ID: 33741725
[TBL] [Abstract][Full Text] [Related]
33. COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention.
Sharma A; Ahmad Farouk I; Lal SK
Viruses; 2021 Jan; 13(2):. PubMed ID: 33572857
[TBL] [Abstract][Full Text] [Related]
34. Similarities and Dissimilarities of COVID-19 and Other Coronavirus Diseases.
Fung TS; Liu DX
Annu Rev Microbiol; 2021 Oct; 75():19-47. PubMed ID: 33492978
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of SARS-CoV-2 and COVID-19.
Hu B; Guo H; Zhou P; Shi ZL
Nat Rev Microbiol; 2021 Mar; 19(3):141-154. PubMed ID: 33024307
[TBL] [Abstract][Full Text] [Related]
36. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19.
Dong M; Zhang J; Ma X; Tan J; Chen L; Liu S; Xin Y; Zhuang L
Biomed Pharmacother; 2020 Nov; 131():110678. PubMed ID: 32861070
[TBL] [Abstract][Full Text] [Related]
37. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.
Korber B; Fischer WM; Gnanakaran S; Yoon H; Theiler J; Abfalterer W; Hengartner N; Giorgi EE; Bhattacharya T; Foley B; Hastie KM; Parker MD; Partridge DG; Evans CM; Freeman TM; de Silva TI; ; McDanal C; Perez LG; Tang H; Moon-Walker A; Whelan SP; LaBranche CC; Saphire EO; Montefiori DC
Cell; 2020 Aug; 182(4):812-827.e19. PubMed ID: 32697968
[TBL] [Abstract][Full Text] [Related]
38. Persistent Symptoms in Patients After Acute COVID-19.
Carfì A; Bernabei R; Landi F;
JAMA; 2020 Aug; 324(6):603-605. PubMed ID: 32644129
[TBL] [Abstract][Full Text] [Related]
39. The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease.
McGonagle D; Sharif K; O'Regan A; Bridgewood C
Autoimmun Rev; 2020 Jun; 19(6):102537. PubMed ID: 32251717
[TBL] [Abstract][Full Text] [Related]
40. Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein.
Hussain M; Jabeen N; Raza F; Shabbir S; Baig AA; Amanullah A; Aziz B
J Med Virol; 2020 Sep; 92(9):1580-1586. PubMed ID: 32249956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
